Sopra Steria reports 2.9% organic decline in Q3, maintains FY25 outlook

Published 29/10/2025, 10:30
Sopra Steria reports 2.9% organic decline in Q3, maintains FY25 outlook

Investing.com -- Sopra Steria reported a 2.9% organic revenue decline in the third quarter, falling short of market expectations of a 1.5% decrease. Shares in the company dropped 3.2%.

The technology consulting firm’s revenue missed analyst estimates by 1-2%, with the UK region being the main underperformer, posting a 9.5% organic decline versus expectations of a 1% drop.

This weakness was attributed to delays in ramping up a major defense program, which the company said has now been launched and should drive growth beginning in 2026.

Despite the disappointing results, Sopra Steria maintained its full-year 2025 guidance of organic revenue growth between -2.5% and +0.5%, and confirmed expectations for positive organic growth in the fourth quarter.

The France region performed better than anticipated with flat growth, as the company noted improving trends in aeronautics, defense, and public sectors. This region is expected to return to positive growth in the fourth quarter.

Meanwhile, the Europe reporting unit declined 3.4% organically, worse than the expected 1.5% decrease. The Other Solutions segment showed a modest 0.4% organic decline.

The company’s workforce increased approximately 1% quarter-over-quarter but decreased about 1.5% year-over-year. Employee attrition rose slightly to 15.3% compared to 14.4% in September 2024.

Sopra Steria is currently searching for a new CEO, focusing on external candidates following Cyril Malargé’s departure to join Alten.

To achieve the midpoint of its full-year guidance, the company would need to deliver approximately 6-6.5% organic revenue growth in the fourth quarter. Analysts suggest Sopra Steria is more likely to land near the lower end of its guidance range, with current market consensus projecting a 1.9% decline for the full year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.